bictegravir
1 January 2025. Related: ARVs, Integrase inhibitors
no separate formulation
Integrase inhibitors
Biktarvy: bictegravir/emtricitabine/TAF
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.
cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
1 August 2024. Related: ARVs, Integrase inhibitors, NNRTIs
(not to scale)
Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.
Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)
dolutegravir
30 August 2024. Related: ARVs, Integrase inhibitors
Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.
Dovato (dolutegravir + lamivudine)
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)
elvitegravir
1 May 2018. Related: ARVs, Integrase inhibitors
Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.
Generic ARVs
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs
A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.
Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
12 April 2016. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster
Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
Juluca (dolutegravir + rilpivirine)
12 May 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs
raltegravir
3 January 2022. Related: ARVs, Integrase inhibitors
Once-daily (600mg) Twice-daily (400 mg)
Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
1 January 2025. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs
Picture not included as there are many different versions.
Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)
Triumeq (dolutegravir + abacavir + 3TC)
30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes
